chicagoest's Recent Posts
Title Rating Company Posted on
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024 2 Zenith Epigenetics Oct 08, 2024 01:00PM
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024 2 Zenith Epigenetics Oct 08, 2024 09:45AM
Re: Just pathetic 1 Resverlogix Corp. Sep 18, 2024 11:30PM
Re: Just pathetic 6 Resverlogix Corp. Sep 16, 2024 08:14PM
Re: Your thoughts please 4 Resverlogix Corp. Sep 09, 2024 04:56PM
Re: Your thoughts please 4 Resverlogix Corp. Sep 09, 2024 03:08PM
Re: Your thoughts please 7 Resverlogix Corp. Sep 08, 2024 02:00PM
Re: Your thoughts please 9 Resverlogix Corp. Sep 07, 2024 10:34PM
Re: Apabetalone inhibits kidney damage in diabetes 7 Resverlogix Corp. Aug 19, 2024 07:51PM
Market Cap - 10.5mil 5 Resverlogix Corp. Jul 24, 2024 01:22PM
2024 Special Annual Meeting 6 Resverlogix Corp. Jun 30, 2024 08:57PM
Re: A Special Meeting of Shareholders? 1 Resverlogix Corp. May 30, 2024 09:07AM
Re: A Special Meeting of Shareholders? Resverlogix Corp. May 29, 2024 12:43PM
Re: A Special Meeting of Shareholders? 6 Resverlogix Corp. May 28, 2024 11:33PM
A Special Meeting of Shareholders? 3 Resverlogix Corp. May 28, 2024 08:57PM
Re: Notice of 2024 Annual Meeting Delayed? 2 Resverlogix Corp. May 23, 2024 11:28AM
Notice of 2024 Annual Meeting Delayed? 2 Resverlogix Corp. May 23, 2024 11:19AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial 1 Zenith Epigenetics May 20, 2024 11:26PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial 2 Zenith Epigenetics May 20, 2024 02:03PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial 3 Zenith Epigenetics May 19, 2024 10:21PM